12 January 2011
Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, will announce its results for the fourth quarter and full year ended 31 December 2010 on Thursday 10 February 2011 at 7.00am GMT/2.00am Eastern time. A presentation for financial analysts will be held at 9.00am GMT/4.00am Eastern time, which can be seen live via webcast on the Smith & Nephew website at www.smith-nephew.com and available on the site archive shortly afterwards.
About Smith & Nephew
Smith & Nephew is a global medical technology business with global leadership positions in Orthopaedics; including Reconstruction, Trauma and Clinical Therapies; Endoscopy; including Sports Medicine; and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company has distribution channels, purchasing agents and buying entities in over 90 countries worldwide. Annual sales in 2009 were nearly $3.8 billion.
Enquiries:
Investors/Analysts |
|
Hannah Longbottom |
Tel: +44 (0) 207 401 7646 |
Corporate Affairs Manager |
|
Smith & Nephew plc |
|
|
|
Media |
|
Jon Coles Brunswick - London |
Tel: +44 (0) 20 7404 5959 |